by Sydney Johnston | Jul 27, 2021 | Research
Published on July 27, 2021 Eduardo Chini, M.D., Ph.D., Mayo Clinic How did you first get involved in PKD research? Eduardo: I’ve trained with Dr. Thomas Dousa one of the found fathers of biochemical nephrology. He studied signal transduction in kidney disease...
by Sydney Johnston | Jun 29, 2021 | Research
Published on June 29, 2021 | On June 1, the STAGED-PKD study was halted due to an inability to meet futility criteria. The study was looking at an investigational drug called venglustat to treat ADPKD. Over 500 patients signed up to participate. What does it mean to...
by Sydney Johnston | Jun 22, 2021 | Research
Published on June 22, 2021 Xiangqin Cui, Ph.D., Emory University How did you first get involved in PKD research? Xiangqin: When I was a postdoc in Dr. Gary Churchill’s lab at the Jackson Laboratory, Dr. Churchill had collaborations with Dr. Lisa Guay-Woodford...
by Sydney Johnston | Jun 10, 2021 | ADPKD Registry, Research
Published on June 8, 2021 | At the PKD Foundation, creating a world free of PKD is our ultimate goal. In order to make that goal a reality, more PKD research is needed. Over the past 40 years, we’ve evolved from not only a funder, but a doer of research....
by Sydney Johnston | May 25, 2021 | Research
Published May 25, 2021 | At the PKD Foundation, funding PKD research is one of our primary functions. Starting last year, caregiver or patient stakeholders joined the research grant review panel to evaluate applications from the patient perspective. We spoke to two of...
by Sydney Johnston | May 4, 2021 | Research
Published on May 4, 2021 Roman-Ulrich Müller, M.D., University of Cologne How did you first get involved in PKD research? Roman: In 2004, I spent a part of my scientific training at Rockefeller University (NYC) in the laboratory of Thomas Tuschl. Thomas is an...
